BACKGROUND: The second-generation cryoballoon (CB2) provides effective and durable pulmonary vein isolation (PVI) associated with encouraging clinical outcome data. The novel third-generation cryoballoon (CB3) incorporates a 40 % shorter distal tip. This design change may translate into an increased rate of PVI real-time signal recording, facilitating an individualized ablation strategy using the time to effect (TTE). METHODS AND RESULTS: Thirty consecutive patients with paroxysmal or short-standing persistent atrial fibrillation underwent CB3-based PVI and were compared to 30 patients treated with the CB2. Individual freeze-cycle duration was set to TTE + 120 s for both groups. A total of 118 (CB3) and 119 (CB2) pulmonary veins (PV) were identified and all PVs successfully isolated utilizing the CB3 and CB2, respectively. The real-time PVI visualization rate was 74 % (CB3) and 40 % (CB2; p = 0.001) and the mean freeze-cycle duration 204 ± 88 s (CB3) and 215 ± 90 s (CB2; p = 0.15). Per individual PV, a shorter mean freeze-duration was found for the CB3 and the right superior PVs (188 ± 92 vs. 211 ± 124 s, p = 0.04) and right inferior PVs (192 ± 75 vs. 200 ± 37 s, p = 0.02). No differences were found for the left-sided PVs. CONCLUSIONS: A higher rate of real-time electrical PV recordings is seen using the novel CB3 as compared to CB2, which may facilitate an individualized ablation strategy using the TTE.
BACKGROUND: The second-generation cryoballoon (CB2) provides effective and durable pulmonary vein isolation (PVI) associated with encouraging clinical outcome data. The novel third-generation cryoballoon (CB3) incorporates a 40 % shorter distal tip. This design change may translate into an increased rate of PVI real-time signal recording, facilitating an individualized ablation strategy using the time to effect (TTE). METHODS AND RESULTS: Thirty consecutive patients with paroxysmal or short-standing persistent atrial fibrillation underwent CB3-based PVI and were compared to 30 patients treated with the CB2. Individual freeze-cycle duration was set to TTE + 120 s for both groups. A total of 118 (CB3) and 119 (CB2) pulmonary veins (PV) were identified and all PVs successfully isolated utilizing the CB3 and CB2, respectively. The real-time PVI visualization rate was 74 % (CB3) and 40 % (CB2; p = 0.001) and the mean freeze-cycle duration 204 ± 88 s (CB3) and 215 ± 90 s (CB2; p = 0.15). Per individual PV, a shorter mean freeze-duration was found for the CB3 and the right superior PVs (188 ± 92 vs. 211 ± 124 s, p = 0.04) and right inferior PVs (192 ± 75 vs. 200 ± 37 s, p = 0.02). No differences were found for the left-sided PVs. CONCLUSIONS: A higher rate of real-time electrical PV recordings is seen using the novel CB3 as compared to CB2, which may facilitate an individualized ablation strategy using the TTE.
Authors: Alexander Fürnkranz; Stefano Bordignon; Daniela Dugo; Laura Perotta; Melanie Gunawardene; Britta Schulte-Hahn; Bernd Nowak; Boris Schmidt; Julian K R Chun Journal: J Cardiovasc Electrophysiol Date: 2014-05-02
Authors: Andreas Metzner; Peter Rausch; Christine Lemes; Bruno Reissmann; Alexander Bardyszewski; Roland Tilz; Andreas Rillig; Shibu Mathew; Sebastian Deiss; Masashi Kamioka; Tobias Toennis; Tina Lin; Feifan Ouyang; Karl-Heinz Kuck; Erik Wissner Journal: J Cardiovasc Electrophysiol Date: 2014-01-30
Authors: Erik Wissner; Christian-Hendrik Heeger; Hanno Grahn; Bruno Reissmann; Peter Wohlmuth; Christine Lemes; Peter Rausch; Shibu Mathew; Andreas Rillig; Sebastian Deiss; Tillman Maurer; Tina Lin; Roland Richard Tilz; Feifan Ouyang; Karl-Heinz Kuck; Andreas Metzner Journal: Europace Date: 2015-04-12 Impact factor: 5.214
Authors: Andreas Metzner; Andre Burchard; Peter Wohlmuth; Peter Rausch; Alexander Bardyszewski; Christina Gienapp; Roland Richard Tilz; Andreas Rillig; Shibu Mathew; Sebastian Deiss; Hisaki Makimoto; Feifan Ouyang; Karl-Heinz Kuck; Erik Wissner Journal: Circ Arrhythm Electrophysiol Date: 2013-06-07
Authors: Andreas Metzner; Christian-Hendrik Heeger; Peter Wohlmuth; Bruno Reißmann; Andreas Rillig; Roland Richard Tilz; Shibu Mathew; Christine Lemes; Sebastian Deiß; Tilman Maurer; Ardan Saguner; Feifan Ouyang; Karl-Heinz Kuck; Erik Wißner Journal: Clin Res Cardiol Date: 2015-07-12 Impact factor: 5.460
Authors: Alexander Fürnkranz; Stefano Bordignon; Boris Schmidt; Melanie Gunawardene; Britta Schulte-Hahn; Verena Urban; Frank Bode; Bernd Nowak; Julian K R Chun Journal: J Cardiovasc Electrophysiol Date: 2013-02-11
Authors: Shaojie Chen; Boris Schmidt; Stefano Bordignon; Fabrizio Bologna; Takahiko Nagase; Laura Perrotta; K R Julian Chun Journal: Arrhythm Electrophysiol Rev Date: 2018-03
Authors: Christian Hendrik Heeger; Sorin Stefan Popescu; Roza Saraei; Bettina Kirstein; Sascha Hatahet; Omar Samara; Anna Traub; Marcel Fehe; Gabriele D'Ambrosio; Ahmad Keelani; Michael Schlüter; Charlotte Eitel; Julia Vogler; Karl Heinz Kuck; Roland Richard Tilz Journal: Europace Date: 2022-07-15 Impact factor: 5.486
Authors: Christian-H Heeger; Erik Wissner; Peter Wohlmuth; Shibu Mathew; Kentaro Hayashi; Christian Sohns; Bruno Reißmann; Christine Lemes; Tilman Maurer; Ardan M Saguner; Francesco Santoro; Johannes Riedl; Feifan Ouyang; Karl-Heinz Kuck; Andreas Metzner Journal: Clin Res Cardiol Date: 2016-04-16 Impact factor: 5.460
Authors: Luigi Sciarra; Saverio Iacopino; Zefferino Palamà; Ermenegildo De Ruvo; Pasquale Filannino; Alessio Borrelli; Paolo Artale; Alberto Caragliano; Antonio Scarà; Paolo Golia; Lucia De Luca; Domenico Grieco; Marco Rebecchi; Stefano Favale; Leonardo Calò Journal: Indian Pacing Electrophysiol J Date: 2018-02-22